FDA批准辉瑞公司(PFE)的蜱传脑炎疫苗_老虎社区_美港股上老虎

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2159465182?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/e559c5a8390713a5a8d4b07a2667368d","is_english":false,"pubTime":"2021-08-16 10:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2159465182","market":"us","top_or_hot":-1,"title":"FDA批准辉瑞公司(PFE)的蜱传脑炎疫苗","media":"凤凰网港股","content":"<html><body><p>凤凰网港股|<span>辉瑞公司(PFE)宣布，美国食品和药物管理局（</span><span>FDA</span><span>）已批准蜱传脑炎疫苗(</span><span>TICOVAC</span><span>)用于主动免疫，以预防1岁及以上个人的TBE。</span></p><p><span>TICOVAC是唯一经</span><span>FDA</span><span>批准的疫苗，</span><span>有助于保护</span><span>美国成年人和儿童</span><span>在访问或生活在TBE流行地区时免受TBE病毒的侵害。在获得FDA批准后，美国疾病控制和预防中心的免疫实践咨询委员会预计将讨论关于安全和适当使用TICOVAC的建议。</span></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FDA批准辉瑞公司(PFE)的蜱传脑炎疫苗</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFDA批准辉瑞公司(PFE)的蜱传脑炎疫苗\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-16 10:18 北京时间&nbsp;&nbsp;&nbsp;<a href=http://hknews.szfuit.com/newRssInfo/feed?original_id=b9938b59ba596518e88cdc30fc8e207e><strong>凤凰网港股</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>凤凰网港股|辉瑞公司(PFE)宣布，美国食品和药物管理局（FDA）已批准蜱传脑炎疫苗(TICOVAC)用于主动免疫，以预防1岁及以上个人的TBE。TICOVAC是唯一经FDA批准的疫苗，有助于保护美国成年人和儿童在访问或生活在TBE流行地区时免受TBE病毒的侵害。在获得FDA批准后，美国疾病控制和预防中心的免疫实践咨询委员会预计将讨论关于安全和适当使用TICOVAC的建议。</p>\n\n<a href=\"http://hknews.szfuit.com/newRssInfo/feed?original_id=b9938b59ba596518e88cdc30fc8e207e\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PFE","symbol_name":"辉瑞","start_time":0,"source_url":"http://hknews.szfuit.com/newRssInfo/feed?original_id=b9938b59ba596518e88cdc30fc8e207e","article_id":"2159465182","we_media_id":"1039806269","thumbnails":["https://static.tigerbbs.com/e559c5a8390713a5a8d4b07a2667368d"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2159465182","pubTimestamp":1629080315,"sourceInfo":null,"weMediaInfo":{"media_name":"凤凰网港股","introduction":"凤凰网港股","home_visible":1,"id":"1039806269","head_image":"https://static.tigerbbs.com/b6fb647077f1ce46dc341fc35c26e817"},"summary":"凤凰网港股|辉瑞公司(PFE)宣布，美国食品和药物管理局（FDA）已批准蜱传脑炎疫苗(TICOVAC)用于主动免疫，以预防1岁及以上个人的TBE。TICOVAC是唯一经FDA批准的疫苗，有助于保护美国成年人和儿童在访问或生活在TBE流行地区时免受TBE病毒的侵害。在获得FDA批准后，美国疾病控制和预防中心的免疫实践咨询委员会预计将讨论关于安全和适当使用TICOVAC的建议。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"PFE":"辉瑞"},"translate_title":"Pfizer (PFE) tick-borne encephalitis vaccine approved by FDA","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PFE":1},"content_text":"凤凰网港股|辉瑞公司(PFE)宣布，美国食品和药物管理局（FDA）已批准蜱传脑炎疫苗(TICOVAC)用于主动免疫，以预防1岁及以上个人的TBE。TICOVAC是唯一经FDA批准的疫苗，有助于保护美国成年人和儿童在访问或生活在TBE流行地区时免受TBE病毒的侵害。在获得FDA批准后，美国疾病控制和预防中心的免疫实践咨询委员会预计将讨论关于安全和适当使用TICOVAC的建议。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[{"id":830578108,"gmtCreate":1629085602104,"gmtModify":1633687511642,"author":{"id":"3585964302651088","authorId":"3585964302651088","name":"GoodLuck0102","avatar":"https://static.tigerbbs.com/344a326f3c2ab4d67b3f22a58a26f13f","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3585964302651088","authorIdStr":"3585964302651088"},"htmlText":"好","listText":"好","text":"好","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/830578108","repostId":2159465182,"repostType":2,"repost":{"id":"2159465182","weMediaInfo":{"introduction":"凤凰网港股","home_visible":1,"media_name":"凤凰网港股","id":"1039806269","head_image":"https://static.tigerbbs.com/b6fb647077f1ce46dc341fc35c26e817"},"pubTimestamp":1629080315,"share":"https://www.laohu8.com/m/news/2159465182?lang=&edition=full","pubTime":"2021-08-16 10:18","market":"us","language":"zh","title":"FDA批准辉瑞公司(PFE)的蜱传脑炎疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=2159465182","media":"凤凰网港股","summary":"凤凰网港股|辉瑞公司(PFE)宣布，美国食品和药物管理局（FDA）已批准蜱传脑炎疫苗(TICOVAC)用于主动免疫，以预防1岁及以上个人的TBE。TICOVAC是唯一经FDA批准的疫苗，有助于保护美国成年人和儿童在访问或生活在TBE流行地区时免受TBE病毒的侵害。在获得FDA批准后，美国疾病控制和预防中心的免疫实践咨询委员会预计将讨论关于安全和适当使用TICOVAC的建议。","content":"<html><body><p>凤凰网港股|<span>辉瑞公司(PFE)宣布，美国食品和药物管理局（</span><span>FDA</span><span>）已批准蜱传脑炎疫苗(</span><span>TICOVAC</span><span>)用于主动免疫，以预防1岁及以上个人的TBE。</span></p><p><span>TICOVAC是唯一经</span><span>FDA</span><span>批准的疫苗，</span><span>有助于保护</span><span>美国成年人和儿童</span><span>在访问或生活在TBE流行地区时免受TBE病毒的侵害。在获得FDA批准后，美国疾病控制和预防中心的免疫实践咨询委员会预计将讨论关于安全和适当使用TICOVAC的建议。</span></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FDA批准辉瑞公司(PFE)的蜱传脑炎疫苗</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFDA批准辉瑞公司(PFE)的蜱传脑炎疫苗\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039806269\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/b6fb647077f1ce46dc341fc35c26e817);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">凤凰网港股 </p>\n<p class=\"h-time\">2021-08-16 10:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>凤凰网港股|<span>辉瑞公司(PFE)宣布，美国食品和药物管理局（</span><span>FDA</span><span>）已批准蜱传脑炎疫苗(</span><span>TICOVAC</span><span>)用于主动免疫，以预防1岁及以上个人的TBE。</span></p><p><span>TICOVAC是唯一经</span><span>FDA</span><span>批准的疫苗，</span><span>有助于保护</span><span>美国成年人和儿童</span><span>在访问或生活在TBE流行地区时免受TBE病毒的侵害。在获得FDA批准后，美国疾病控制和预防中心的免疫实践咨询委员会预计将讨论关于安全和适当使用TICOVAC的建议。</span></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/e559c5a8390713a5a8d4b07a2667368d","relate_stocks":{},"source_url":"http://hknews.szfuit.com/newRssInfo/feed?original_id=b9938b59ba596518e88cdc30fc8e207e","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2159465182","content_text":"凤凰网港股|辉瑞公司(PFE)宣布，美国食品和药物管理局（FDA）已批准蜱传脑炎疫苗(TICOVAC)用于主动免疫，以预防1岁及以上个人的TBE。TICOVAC是唯一经FDA批准的疫苗，有助于保护美国成年人和儿童在访问或生活在TBE流行地区时免受TBE病毒的侵害。在获得FDA批准后，美国疾病控制和预防中心的免疫实践咨询委员会预计将讨论关于安全和适当使用TICOVAC的建议。","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}

FDA批准辉瑞公司(PFE)的蜱传脑炎疫苗

评论（1）

热议股票

7x24